← back to search

Min Yuen Teo

National Cancer Institute · US
🔎 Find collaborators in Surgery · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Surgery · Oncology
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, and Prostate Cancer Treatment and Research.
h-index
27
citations
4,350
works
171
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
European Urology 2025cited by 15position: middledoi
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer
Nature Communications 2025cited by 6position: middledoi
AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation.
Journal of Clinical Oncology 2024cited by 40position: middledoi
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Clinical Cancer Research 2023cited by 62position: middledoi
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
Cell 2022cited by 637position: middledoi
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
Journal of Clinical Oncology 2022cited by 97position: middledoi
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
Cell Reports 2022cited by 66position: middledoi
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Clinical Genitourinary Cancer 2022cited by 32position: firstdoi
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
BMC Cancer 2021cited by 58position: middledoi
Rucaparib for recurrent, locally advanced, or metastatic urothelial carcinoma (mUC): Results from ATLAS, a phase II open-label trial.
Journal of Clinical Oncology 2020cited by 28position: middledoi
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Journal of Clinical Oncology 2018cited by 549position: firstdoi
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
Journal of Neuro-Oncology 2013cited by 216position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David B. Solit · New York Oncology Hematology4 papers (2018–2025)Hikmat Al‐Ahmadie · Queen Mary University of London4 papers (2018–2025)Petros Grivas · Second Foundation (United States)3 papers (2020–2024)Michael F. Berger · Memorial Sloan Kettering Cancer Center3 papers (2018–2023)Jonathan E. Rosenberg · New York Oncology Hematology3 papers (2022–2024)Gopa Iyer · New York Oncology Hematology3 papers (2018–2023)Dean F. Bajorin · Kettering University3 papers (2018–2023)Carissa Chu · Memorial Sloan Kettering Cancer Center3 papers (2022–2025)Yohann Loriot · Institut Gustave Roussy2 papers (2020–2021) · 2 papers (2020–2021)Eugene J. Pietzak · Memorial Sloan Kettering Cancer Center2 papers (2022–2023)Enrique Grande · Hospital Universitario Quirónsalud Madrid2 papers (2020–2021)Debra H. Josephs · Guy's Hospital2 papers (2020–2021)Ajjai Alva · University of Colorado Anschutz Medical Campus2 papers (2020–2021)Yousef Zakharia · SUNY Upstate Medical University2 papers (2020–2021)Nabil Adra · Indiana University Health2 papers (2020–2021)Irina Ostrovnaya · Memorial Sloan Kettering Cancer Center2 papers (2018–2022)Nicholas J. Vogelzang · Comprehensive Cancer Centers of Nevada2 papers (2020–2021) · 2 papers (2020–2021)Ashley Marie Regazzi · Memorial Sloan Kettering Cancer Center2 papers (2018–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Oncology →